CARD15 mutations and colorectal cancer in a South European country

International Journal of Colorectal Disease

Volumn 25, Issue 10, 2010, Pages 1211-1219

  Freire, Paulo ^a   Portela, Francisco ^a   Donato, Maria M ^b   Figueiredo, Pedro ^a,b   Ferreira, Manuela ^a   Amaro, Pedro ^a   Sá, Anabela ^a   Andrade, Paulo ^a   Gouveia, Hermano ^a   Sofia, Carlos ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

CARD15; Colorectal cancer; Inflammation; Susceptibility

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERMLINE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOMATIC MUTATION;

AGE FACTORS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PORTUGAL; RISK FACTORS; SEX FACTORS;

EID: 77956186833     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1028-0     Document Type: Article

References (42)

1. P Boyle JS Langman 2000 ABC of colorectal cancer: epidemiology BMJ 321 805 808 10.1136/bmj.321.7264.805 1:STN:280:DC%2BD3M%2FhvFamsw%3D%3D 11009523
2. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 543 10.1016/S1470-2045(01)00486-7 1:STN:280:DC%2BD387ntlCrtw%3D%3D 11905707
3. J Ferlay P Autier M Boniol, et al. 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581 592 10.1093/annonc/mdl498 1:STN:280:DC%2BD2s7hslSgtw%3D%3D 17287242
4. S Tejpar E Van Cutsem 2002 Molecular and genetic defects in colorectal tumorigenesis Best Pract Res Clin Gastroenterol 16 171 185 10.1053/bega.2001. 0279 1:CAS:528:DC%2BD3sXktlSqsb4%3D 11969232
5. PL Lakatos L Lakatos 2006 Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome Orv Hetil 147 449 455 16573174
6. S Popat R Wort RS Houlston 2006 Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance BMC Cancer 6 150 10.1186/1471-2407-6- 150 16753067
7. P Fuszek P Lakatos A Tabak, et al. 2004 Relationship between serum calcium and CA 19-9 levels in colorectal cancer World J Gastroenterol 10 1890 1892 1:CAS:528:DC%2BD2cXmslWrtLo%3D 15222030
8. JM Rhodes BJ Campbell 2002 Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared Trends Mol Med 8 10 16 10.1016/S1471-4914(01)02194-3 1:CAS:528:DC%2BD38Xls1CjsQ%3D%3D 11796261
9. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D 12490959
10. MP Williams RE Pounder 1999 Helicobacter pylori: from the benign to the malignant Am J Gastroenterol 94 S11 S16 10.1016/S0002-9270(99)00657-7 1:STN:280:DC%2BD3c%2FivFegtg%3D%3D 10565604
11. P Munkholm 2003 Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease Aliment Pharmacol Ther 18 1 5 10.1046/j.1365-2036.18.s2.2.x 12950413
12. S Higaki A Akazawa H Nakamura, et al. 1999 Metaplastic polyp of the colon develops in response to inflammation J Gastroenterol Hepatol 14 709 714 10.1046/j.1440-1746.1999.01938.x 1:STN:280:DyaK1Mzms1yhuw%3D%3D 10440217
13. CE Eberhart RJ Coffey A Radhika, et al. 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 1:STN:280:DyaK2M%2FhtFamsA%3D%3D 7926468
14. N Phoa B Epe 2002 Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells Carcinogenesis 23 469 475 10.1093/carcin/23.3.469 1:CAS:528:DC%2BD38Xis1KntLc%3D 11895862
15. AL Jackson LA Loeb 2001 The contribution of endogenous sources of DNA damage to the multiple mutations in cancer Mutat Res 477 7 21 1:CAS:528:DC%2BD3MXjslenu7s%3D 11376682
16. MA Moore 2002 Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing J Cell Biochem 38 29 38 10.1002/jcb.10105
17. N Nakajima H Kuwayama Y Ito, et al. 1997 Helicobacter pylori, neutrophils, interleukins, and gastric epithelial proliferation J Clin Gastroenterol 25 S198 S202 10.1097/00004836-199700001-00031 9479648
18. JR Jackson MP Seed CH Kircher, et al. 1997 The codependence of angiogenesis and chronic inflammation FASEB J 11 457 465 1:CAS:528: DyaK2sXjvFahsb8%3D 9194526
19. C Dubé A Rostom G Lewin, et al. 2007 The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. preventive services task force Ann Intern Med 146 365 375 17339622
20. RC Orlando 2002 Mechanisms of epithelial injury and inflammation in gastrointestinal diseases Rev Gastroenterol Disord 2 S2 S8 12478238
21. JP Hugot M Chamaillard H Zouali, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 10.1038/35079107 1:CAS:528:DC%2BD3MXksVShtLY%3D 11385576
22. Y Ogura DK Bonen N Inohara, et al. 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 603 606 10.1038/35079114 1:CAS:528:DC%2BD3MXksVShur8%3D 11385577
23. S Lesage H Zouali JP Cézard, et al. 2002 CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease Am J Hum Genet 70 845 857 10.1086/339432 1:CAS:528: DC%2BD38XivFClurw%3D 11875755
24. J Hampe A Cuthbert PJ Croucher, et al. 2001 Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations Lancet 357 1925 1928 10.1016/S0140-6736(00)05063-7 1:CAS:528: DC%2BD3MXks1OisLk%3D 11425413
25. T Heliö L Halme M Lappalainen, et al. 2003 CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease Gut 52 558 562 10.1136/gut.52.4.558 12631669
26. G Kurzawski J Suchy J Kładny, et al. 2004 The NOD2 3020insC mutation and the risk of colorectal cancer Cancer Res 64 1604 1606 10.1158/0008-5472.CAN-03-3791 1:CAS:528:DC%2BD2cXhsl2iur4%3D 14996717
27. I Papaconstantinou G Theodoropoulos M Gazouli, et al. 2005 Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population Int J Cancer 114 433 435 10.1002/ijc.20747 1:CAS:528: DC%2BD2MXhvFKksLs%3D 15578724
28. P Alhopuro T Ahvenainen JP Mecklin, et al. 2004 NOD2 3020insC alone is not sufficient for colorectal cancer predisposition Cancer Res 64 7245 7247 10.1158/0008-5472.CAN-04-2364 1:CAS:528:DC%2BD2cXosFynt70%3D 15492242
29. S Tuupanen P Alhopuro JP Mecklin, et al. 2007 No evidence for association of NOD2 R702W and G908R with colorectal cancer Int J Cancer 121 76 79 10.1002/ijc.22651 1:CAS:528:DC%2BD2sXlsVajsr4%3D 17351900
30. RL Roberts RB Gearry MD Allington, et al. 2006 Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer Cancer Res 66 2532 2535 10.1158/0008-5472.CAN-05-4165 1:CAS:528:DC%2BD28XhvV2htL0%3D 16510569
31. PL Lakatos E Hitre F Szalay, et al. 2007 Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients BMC Cancer 7 54 10.1186/1471-2407-7-54 17389035
32. N Möckelmann W von Schönfels S Buch, et al. 2009 Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer BMC Gastroenterol 9 79 10.1186/1471-230X-9-79 19843337
33. ID Arnott ER Nimmo HE Drummond, et al. 2004 NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 5 417 425 10.1038/sj.gene.6364111 1:CAS:528:DC%2BD2cXlvValsLc%3D 15190267
34. PJ Croucher S Mascheretti J Hampe, et al. 2003 Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations Eur J Hum Genet 11 6 16 10.1038/sj.ejhg.5200897 1:CAS:528: DC%2BD3sXht12hurs%3D 12529700
35. DR Gaya RK Russell ER Nimmo, et al. 2006 New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367 1271 1284 10.1016/S0140- 6736(06)68345-1 1:CAS:528:DC%2BD28Xjsl2ktLg%3D 16631883
36. L Henckaerts K Van Steen I Verstreken, et al. 2009 Genetic risk profiling and prediction of disease course in Crohn's disease patients Clin Gastroenterol Hepatol 7 972 980 10.1016/j.cgh.2009.05.001 1:CAS:528:DC%2BD1MXhsFent7nL 19422935
37. V Annese G Lombardi F Perri, et al. 2005 Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-an IG-IBD study Am J Gastroenterol 100 84 92 10.1111/j.1572-0241.2005.40705.x 1:CAS:528:DC%2BD2MXht12rurw%3D 15654786
38. J Hampe J Grebe S Nikolaus, et al. 2002 Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study Lancet 359 1661 1665 10.1016/S0140-6736(02)08590-2 1:CAS:528:DC%2BD38XjvVWjs70%3D 12020527
39. MT Abreu KD Taylor YC Lin, et al. 2002 Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease Gastroenterology 123 679 688 10.1053/gast.2002.35393 1:CAS:528:DC%2BD38Xntl2mtbo%3D 12198692
40. M Economou TA Trikalinos KT Loizou, et al. 2004 Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis Am J Gastroenterol 99 2393 2404 10.1111/j.1572-0241.2004.40304.x 1:CAS:528:DC%2BD2MXmsFyquw%3D%3D 15571588
41. G Radford-Smith N Pandeya 2006 Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease-are we there yet? World J Gastroenterol 12 7097 7103 17131470
42. JI Allen 1995 Molecular biology of colon polyps and colon cancer Semin Surg Oncol 11 399 405 10.1002/ssu.2980110606 1:STN:280:DyaK287ptFKitQ%3D%3D 8607008